Twist Bioscience (TWST) insider sale notice: 7,470 shares sold; 206 more offered
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
TWST Form 144 summary: This notice reports proposed and recent sales of Twist Bioscience common stock by an individual identified as Patrick Finn. The filer proposes to sell 206 shares via Fidelity Brokerage with an aggregate market value of $6,007.15 and lists the company's outstanding share count as 60,360,925. The 206 shares were acquired on 10/01/2025 through restricted stock vesting and payment is listed as compensation. The filing also discloses four reported sales in the prior three months totaling 7,470 shares for $225,564.62. The signer represents they have no undisclosed material information about the issuer.
Positive
- None.
Negative
- Insider sold 7,470 shares in the past three months for $225,564.62
- Proposed sale of 206 shares (aggregate market value $6,007.15) to be executed on 10/02/2025
FAQ
Who is the seller named in the TWST Form 144?
The filing lists Patrick Finn as the person for whose account the securities were or will be sold.
What recent insider sales are disclosed in this TWST filing?
Four sales in the prior three months totaling 7,470 shares for $225,564.62 (dates: 07/02/2025, 07/23/2025, 08/04/2025, 08/21/2025).